Annual Mood Disorder Symposium April 5
The fourth annual
, presented by the
, is scheduled for Saturday, April 5, at the Conference Center at Drake, 151 W. Galbraith Road. The theme is, "Novel Treatment Approaches for Depression.
Registration is at 7 a.m., with faculty presentations beginning at 8 following a welcome and overview by Stephen Strakowski, MD, the Dr. Stanley and Mickey Kaplan Professor and Chair of Psychiatry and Behavioral Neuroscience.
In addition to novel treatment options, topics will include new non-pharmacologic strategies for treating depression and the impact of neurodevelopmental changes on depression treatment. Course co-directors are Cal Adler, MD, Stephen Benoit, PhD, and Melissa DelBello, MD.
Continuing education credit is available. Fees are $75 in advance for physicians ($90 at the door); $75 for nurses, $50 for mental health professionals, $25 for residents and students (UC psychiatry residents free).
For more information, contact Sonya Kirkland at 513-558-4866 or
.
Tags
Related Stories
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.